{"oncoTreeVersion":"oncotree_2019_12_01","ncitVersion":"19.03d","levels":[{"levelOfEvidence":"LEVEL_1","description":"FDA-recognized biomarker predictive of response to an FDA-approved drug in this indication","htmlDescription":"<span><b>FDA-recognized</b> biomarker predictive of response to an <b>FDA-approved</b> drug <b>in this indication</b></span>","colorHex":"#33A02C"},{"levelOfEvidence":"LEVEL_2","description":"Standard care biomarker recommended by the NCCN or other expert panels predictive of response to an FDA-approved drug in this indication","htmlDescription":"<span><b>Standard care</b> biomarker recommended by the NCCN or other expert panels predictive of response to an <b>FDA-approved drug</b> in this indication</span>","colorHex":"#1F78B4"},{"levelOfEvidence":"LEVEL_2A","description":"Standard care biomarker recommended by the NCCN or other expert panels predictive of response to an FDA-approved drug in this indication","htmlDescription":"<span><b>Standard care</b> biomarker recommended by the NCCN or other expert panels predictive of response to an <b>FDA-approved drug</b> in this indication</span>","colorHex":"#1F78B4"},{"levelOfEvidence":"LEVEL_2B","description":"","htmlDescription":"","colorHex":"#80B1D3"},{"levelOfEvidence":"LEVEL_3A","description":"Compelling clinical evidence supports the biomarker as being predictive of response to a drug in this indication","htmlDescription":"<span><b>Compelling clinical evidence</b> supports the biomarker as being predictive of response to a drug <b>in this indication</b> but neither biomarker and drug are standard of care</span>","colorHex":"#984EA3"},{"levelOfEvidence":"LEVEL_3B","description":"Standard care or investigational biomarker predictive of response to an FDA-approved or investigational drug in another indication","htmlDescription":"<span><b>Standard care</b> or <b>investigational</b> biomarker predictive of response to an <b>FDA-approved</b> or <b>investigational</b> drug in another indication</span>","colorHex":"#BE98CE"},{"levelOfEvidence":"LEVEL_4","description":"Compelling biological evidence supports the biomarker as being predictive of response to a drug","htmlDescription":"<span><b>Compelling biological evidence</b> supports the biomarker as being predictive of response to a drug but neither biomarker and drug are standard of care</span>","colorHex":"#424242"},{"levelOfEvidence":"LEVEL_R1","description":"Standard care biomarker predictive of resistance to an FDA-approved drug in this indication","htmlDescription":"<span><b>Standard of care</b> biomarker predictive of <b>resistance</b> to an <b>FDA-approved</b> drug <b>in this indication</b></span>","colorHex":"#EE3424"},{"levelOfEvidence":"LEVEL_R2","description":"Compelling clinical evidence supports the biomarker as being predictive of resistance to a drug","htmlDescription":"<span><b>Compelling clinical evidence</b> supports the biomarker as being predictive of <b>resistance</b> to a drug</span>","colorHex":"#F79A92"}],"dataVersion":{"version":"","date":""},"apiVersion":"v1.2.0","publicInstance":false}